Doctors told CNN that they are receiving more and more reports of gastrointestinal issues in patients who have taken the following similar diabetes/weight loss drugs: As the popularity of the drugs has soared, the US Food and Drug Administration told CNN it had received reports of gastroparesis with semaglutide and liraglutide, some of which documented the adverse event as not recovered after discontinuation of the respective product at the time of the report. (Novos Ozempic and a similar drug, Wegovy, utilize the same medication semaglutide
Easy measuring: At ~3,333 mcg/mL, 300 mcg 9 units and 500 mcg 15 units on a U-100 insulin syringe
Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury
Supplement with Zinc : Adding a zinc supplement to your regimen can maintain balanced levels
Sleep matters more than people expect
This work was supported by a pilot grant from the HIV and Aging Grant CFAR-UAB (R24 AG044325), and a philanthropic donation received from the McNair Medical Institute at The Robert and Janice McNair Foundation.